Competitive and noncompetitive inhibition of the DNA-dependent protein kinase - PubMed (original) (raw)
. 1999 Jun 1;59(11):2581-6.
Affiliations
- PMID: 10363977
Competitive and noncompetitive inhibition of the DNA-dependent protein kinase
R A Izzard et al. Cancer Res. 1999.
Abstract
The DNA-dependent protein kinase (DNA-PK) is a serine/threonine protein kinase that is involved in mammalian DNA double-strand break repair. The catalytic subunit of DNA-PK (DNA-PKcs) shares sequence homology in its kinase domain with phosphatidylinositol (PI) 3-kinase. Here, we provide a detailed kinetic analysis of DNA-PK inhibition by the PI 3-kinase inhibitor wortmannin and demonstrate this inhibition to be of a noncompetitive nature, with a Ki of 120 nM. Another inhibitor of PI 3-kinase. LY294002, its parent compound, quercetin, and other derivatives have also been studied. These chemicals are competitive inhibitors of DNA-PK, with LY294002 having a Ki of 6.0 microM. Using an antibody to wortmannin, we found that this compound binds covalently to the kinase domain of DNA-PKcs both in vitro and in vivo. Binding of wortmannin to the active site of DNA-PKcs is inhibited by ATP but not by a peptide substrate. Furthermore, wortmannin is able to bind to DNA-PKcs independently of Ku, and it is not stimulated by the presence of DNA. This suggests that the ATP binding site of DNA-PKcs is open constitutively and that DNA activation of the kinase is mediated via another mechanism.
Similar articles
- DNA-dependent protein kinase and related proteins.
Smith GC, Divecha N, Lakin ND, Jackson SP. Smith GC, et al. Biochem Soc Symp. 1999;64:91-104. Biochem Soc Symp. 1999. PMID: 10207623 Review. - Wortmannin inhibits repair of DNA double-strand breaks in irradiated normal human cells.
Okayasu R, Suetomi K, Ullrich RL. Okayasu R, et al. Radiat Res. 1998 May;149(5):440-5. Radiat Res. 1998. PMID: 9588354 - Small molecule inhibitors of the PI3-kinase family.
Knight ZA. Knight ZA. Curr Top Microbiol Immunol. 2010;347:263-78. doi: 10.1007/82_2010_44. Curr Top Microbiol Immunol. 2010. PMID: 20473788 Review.
Cited by
- Development and Evolution of DNA-Dependent Protein Kinase Inhibitors toward Cancer Therapy.
Matsumoto Y. Matsumoto Y. Int J Mol Sci. 2022 Apr 12;23(8):4264. doi: 10.3390/ijms23084264. Int J Mol Sci. 2022. PMID: 35457081 Free PMC article. Review. - Emerging Therapeutic Targets Against Toxoplasma gondii: Update on DNA Repair Response Inhibitors and Genotoxic Drugs.
Angel SO, Vanagas L, Ruiz DM, Cristaldi C, Saldarriaga Cartagena AM, Sullivan WJ Jr. Angel SO, et al. Front Cell Infect Microbiol. 2020 Jun 12;10:289. doi: 10.3389/fcimb.2020.00289. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32656097 Free PMC article. Review. - DNA-PKcs chemical inhibition versus genetic mutation: Impact on the junctional repair steps of V(D)J recombination.
Anne Esguerra Z, Watanabe G, Okitsu CY, Hsieh CL, Lieber MR. Anne Esguerra Z, et al. Mol Immunol. 2020 Apr;120:93-100. doi: 10.1016/j.molimm.2020.01.018. Epub 2020 Feb 26. Mol Immunol. 2020. PMID: 32113132 Free PMC article. - Pan-class I PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53.
Müller A, Gillissen B, Richter A, Richter A, Chumduri C, Daniel PT, Scholz CW. Müller A, et al. Cell Death Dis. 2018 Mar 7;9(3):384. doi: 10.1038/s41419-018-0413-4. Cell Death Dis. 2018. PMID: 29515122 Free PMC article. - The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.
Sishc BJ, Davis AJ. Sishc BJ, et al. Cancers (Basel). 2017 Jul 6;9(7):81. doi: 10.3390/cancers9070081. Cancers (Basel). 2017. PMID: 28684677 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous